COMBIVIR
Land: Ísrael
Tungumál: enska
Heimild: Ministry of Health
Upplýsingar fylgiseðill
(PIL)
27-11-2018
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
LAMIVUDINE; ZIDOVUDINE
Fáanlegur frá:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC númer:
J05AF05
Lyfjaform:
FILM COATED TABLETS
Samsetning:
LAMIVUDINE 150 MG; ZIDOVUDINE 300 MG
Stjórnsýsluleið:
PER OS
Gerð lyfseðils:
Required
Framleitt af:
GLAXO SMITH KLINE PHARMACEUTICALS S.A., POLAND
Lækningarsvæði:
LAMIVUDINE
Ábendingar:
Combivir is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection.
Leyfisdagur:
2015-10-20
Upplýsingar fylgiseðill
רבמבונ
2018 :ןודנה
ריויבמוק
תופוצמ תוילבט
FILM COATED TABLETS
COMBIVIR
ה/דבכנ ה/אפור
,ה/דבכנ ת/חקור
( מ"עב לארשי ןיילקתימסוסקלג תרבח
GSK
ולעה ןוכדע לע עידוהל תשקבמ )
ן
אפורל
לש
רישכתה
COMBIVIR
םייונישה םילולכ וז העדוהב
םייתוהמה
אפורל ןולעב
.
.ןכרצל ןולעב יוניש ןיא
:םקזוחו םיליעפ םיביכרמ
Lamivudine – 150 mg
Zidovudine – 300 mg :לארשיב רישכתל המושרה היוותה
Combivir is indicated in antiretroviral combination therapy for the
treatment of Human
Immunodeficiency Virus (HIV) infection.
ה
ע םינוכד
נ םיאבה םיפיעסב ושע
ב
: אפורל ןולע
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
…
_Immune Reactivation Syndrome:_
…Autoimmune disorders (such as Graves’ disease and autoimmune
hepatitis) have also been reported to occur
in the setting of immune reactivation; however, the reported time to
onset is more variable and these events
can occur many months after initiation of treatment.
_ _
…
4.8
UNDESIRABLE EFFECTS
…
In HIV-infected patients with severe immune deficiency at the time of
initiation of combination antiretroviral
therapy (CART), an inflammatory reaction to asymptomatic or residual
opportunistic infections may arise.
Autoimmune disorders (such as Graves’ disease and autoimmune
hepatitis) have also been reported to occur
in the setting of immune reactivation; however, the reported time to
onset is more variable and these events
can occur many months after initiation of treatment (see section 4.4).
…
: םינמוסמה םינוכדעל ארקמ
רסוהש עדימ
–
הצוח םודא וקב ןמוסמ
XXX
תפסות
–
בתכ
לוחכ
הרמחה תפסות
-
בתכ
לוחכ
–
רקרמ בוהצב ןמוסמ
ולעה
ן
אפורל
חלשנ
םוסרפל
רגאמב
תופורתה
רתאבש
דרשמ
תואירבה
:
https://www.old.health.gov.il/units/pharmacy/tr
Lestu allt skjalið
